{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=43", "query": { "intervention": "CTRL", "page": 43 }, "page_size": 10 }, "pagination": { "page": 43, "page_size": 10, "total_count": 26651, "total_pages": 2666, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=44&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=CTRL&page=42&page_size=10" }, "source": "remote", "last_synced_at": "2026-11-07T13:35:20.067Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01214967", "title": "Problem Solving Education and Neonatal Intensive Care Unit (NICU) Mothers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Maternal Depression" ], "interventions": [ { "name": "Problem Solving Education", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "15 Years", "maximum_age": null, "sex": "FEMALE", "summary": "15 Years and older · Female only" }, "enrollment_count": 50, "start_date": "2008-10", "completion_date": "2010-06", "has_results": false, "last_update_posted_date": "2016-10-10", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 2, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01214967" }, { "nct_id": "NCT01784627", "title": "Trial of Computerized SBI to Reduce Teen Alcohol Use", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Alcohol Abuse", "Cannabis Abuse", "Nicotine Dependence" ], "interventions": [ { "name": "c-ASBI", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Boston Children's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "9 Years", "maximum_age": "20 Years", "sex": "ALL", "summary": "9 Years to 20 Years" }, "enrollment_count": 0, "start_date": "2015-01", "completion_date": "2017-10", "has_results": false, "last_update_posted_date": "2016-10-07", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 6, "location_summary": "Boston, Massachusetts • Cambridge, Massachusetts • Lexington, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "Cambridge", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT01784627" }, { "nct_id": "NCT02174627", "title": "Safety and Efficacy Study of Roxadustat to Treat Anemia in Patients With Chronic Kidney Disease (CKD), Not on Dialysis", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Anemia" ], "interventions": [ { "name": "Roxadustat", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "AstraZeneca", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "130 Years", "sex": "ALL", "summary": "18 Years to 130 Years" }, "enrollment_count": 2781, "start_date": "2014-06-26", "completion_date": "2018-10-04", "has_results": true, "last_update_posted_date": "2019-12-16", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 97, "location_summary": "Birmingham, Alabama • Huntsville, Alabama • Phoenix, Arizona + 72 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Huntsville", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Bakersfield", "state": "California" }, { "city": "El Centro", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT02174627" }, { "nct_id": "NCT01081886", "title": "PEAK PlasmaBlade 4.0 Versus Traditional Electrosurgery in Total Knee Replacement.", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Degenerative Joint Disease", "Osteoarthritis" ], "interventions": [ { "name": "PEAK PlasmaBlade 4.0", "type": "DEVICE" }, { "name": "Traditional Electrosurgery with scalpel", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Medtronic Surgical Technologies", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "21 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "21 Years to 80 Years" }, "enrollment_count": 24, "start_date": "2010-06", "completion_date": "2011-09", "has_results": true, "last_update_posted_date": "2013-01-08", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 2, "location_summary": "Rochester Hills, Michigan • Arlington, Texas", "locations": [ { "city": "Rochester Hills", "state": "Michigan" }, { "city": "Arlington", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT01081886" }, { "nct_id": "NCT00518973", "title": "Trial of Quetiapine in Anorexia Nervosa", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Anorexia Nervosa" ], "interventions": [ { "name": "Quetiapine", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of California, San Diego", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2006-07", "completion_date": "2010-05", "has_results": true, "last_update_posted_date": "2019-07-17", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 1, "location_summary": "San Diego, California", "locations": [ { "city": "San Diego", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00518973" }, { "nct_id": "NCT01925469", "title": "Benzocaine Versus Placebo Spray for Pain Relief at Hysterosalpingogram", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Pain Relief", "Analgesia" ], "interventions": [ { "name": "Benzocaine", "type": "DRUG" }, { "name": "Saline spray", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pennsylvania", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "FEMALE", "summary": "18 Years and older · Female only" }, "enrollment_count": 30, "start_date": "2011-12", "completion_date": "2012-04", "has_results": true, "last_update_posted_date": "2017-04-28", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT01925469" }, { "nct_id": "NCT00332241", "title": "Study of Aripiprazole in the Treatment of Children and Adolescents With Autistic Disorder (AD).", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Autistic Disorder" ], "interventions": [ { "name": "Aripiprazole", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Otsuka Pharmaceutical Development & Commercialization, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "6 Years", "maximum_age": "17 Years", "sex": "ALL", "summary": "6 Years to 17 Years" }, "enrollment_count": 98, "start_date": "2006-06-01", "completion_date": "2008-04-01", "has_results": true, "last_update_posted_date": "2026-05-13", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 9, "location_summary": "Boca Raton, Florida • Atlanta, Georgia • Louisville, Kentucky + 6 more", "locations": [ { "city": "Boca Raton", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Louisville", "state": "Kentucky" }, { "city": "Bloomfield Hills", "state": "Michigan" }, { "city": "Las Vegas", "state": "Nevada" } ], "official_url": "https://clinicaltrials.gov/study/NCT00332241" }, { "nct_id": "NCT05298254", "title": "A Study on the Reactogenicity, Safety, Immune Response, and Efficacy of a Targeted Immunotherapy Against HSV in Healthy Participants Aged 18-40 Years or in Participants Aged 18-60 Years With Recurrent Genital Herpes", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Herpes Simplex" ], "interventions": [ { "name": "Non-adjuvanted HSV formulation 1", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 2", "type": "BIOLOGICAL" }, { "name": "Non-adjuvanted HSV formulation 3", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 1", "type": "BIOLOGICAL" }, { "name": "HSV formulation 1 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 2 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "HSV formulation 3 with adjuvant 2", "type": "BIOLOGICAL" }, { "name": "Placebo", "type": "DRUG" }, { "name": "HSVTI_F1", "type": "BIOLOGICAL" }, { "name": "HSVTI_F2", "type": "BIOLOGICAL" } ], "intervention_types": [ "BIOLOGICAL", "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "60 Years", "sex": "ALL", "summary": "18 Years to 60 Years" }, "enrollment_count": 505, "start_date": "2022-03-07", "completion_date": "2025-06-12", "has_results": false, "last_update_posted_date": "2025-09-08", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 6, "location_summary": "Phoenix, Arizona • Wichita, Kansas • Kansas City, Missouri + 3 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Wichita", "state": "Kansas" }, { "city": "Kansas City", "state": "Missouri" }, { "city": "Rochester", "state": "New York" }, { "city": "Richmond", "state": "Virginia" } ], "official_url": "https://clinicaltrials.gov/study/NCT05298254" }, { "nct_id": "NCT04987294", "title": "Phase IIa Study of ALLN-346 (Engineered Urate Oxidase) in Subjects With Hyperuricemia, Gout and Chronic Kidney Disease", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Hyperuricemia", "Gout", "Chronic Kidney Diseases" ], "interventions": [ { "name": "ALLN-346", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Allena Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 19, "start_date": "2022-09-02", "completion_date": "2022-09-02", "has_results": false, "last_update_posted_date": "2023-06-23", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 17, "location_summary": "Birmingham, Alabama • Muscle Shoals, Alabama • Sheffield, Alabama + 12 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Muscle Shoals", "state": "Alabama" }, { "city": "Sheffield", "state": "Alabama" }, { "city": "Anchorage", "state": "Alaska" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT04987294" }, { "nct_id": "NCT03482453", "title": "A Study to Evaluate the Pharmacokinetics (PK), Safety and Tolerability of TAK-788 Followed by Evaluation of the Effects of a Low-Fat Meal on TAK-788 PK and Evaluation of Relative Bioavailability of TAK-788 Capsules in Healthy Participants", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy Volunteers" ], "interventions": [ { "name": "TAK-788", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Millennium Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "55 Years", "sex": "ALL", "summary": "18 Years to 55 Years" }, "enrollment_count": 69, "start_date": "2018-03-28", "completion_date": "2019-01-18", "has_results": true, "last_update_posted_date": "2020-01-29", "last_synced_at": "2026-11-07T13:35:20.067Z", "location_count": 1, "location_summary": "Salt Lake City, Utah", "locations": [ { "city": "Salt Lake City", "state": "Utah" } ], "official_url": "https://clinicaltrials.gov/study/NCT03482453" } ] }